185 related articles for article (PubMed ID: 14978753)
41. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
42. Lentiviral vector gene transfer into human T cells.
Verhoeyen E; Costa C; Cosset FL
Methods Mol Biol; 2009; 506():97-114. PubMed ID: 19110622
[TBL] [Abstract][Full Text] [Related]
43. Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.
Jung C; Grzybowski BN; Tong S; Cheng L; Compans RW; Le Doux JM
Biotechnol Prog; 2004; 20(6):1810-6. PubMed ID: 15575716
[TBL] [Abstract][Full Text] [Related]
44. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
45. Biology and application of alphaviruses in gene therapy.
Lundstrom K
Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
[TBL] [Abstract][Full Text] [Related]
46. Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.
Schauber-Plewa C; Simmons A; Tuerk MJ; Pacheco CD; Veres G
Gene Ther; 2005 Feb; 12(3):238-45. PubMed ID: 15550926
[TBL] [Abstract][Full Text] [Related]
47. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model.
Moreno R; Rosal M; Martinez I; Vilardell F; Gonzalez JR; Petriz J; Hernandez-Andrade E; Gratacós E; Aran JM
J Gene Med; 2008 Sep; 10(9):951-64. PubMed ID: 18613266
[TBL] [Abstract][Full Text] [Related]
48. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
49. Safety features of retroviral vectors.
Hansen AC; Pedersen FS
Curr Opin Mol Ther; 2002 Aug; 4(4):324-33. PubMed ID: 12222870
[TBL] [Abstract][Full Text] [Related]
50. Non-primate lentiviral vectors.
Poeschla EM
Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
[TBL] [Abstract][Full Text] [Related]
51. Altering the tropism of lentiviral vectors through pseudotyping.
Cronin J; Zhang XY; Reiser J
Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
[TBL] [Abstract][Full Text] [Related]
52. Retroviral cell targeting vectors.
Buchholz CJ; Stitz J; Cichutek K
Curr Opin Mol Ther; 1999 Oct; 1(5):613-21. PubMed ID: 11249668
[TBL] [Abstract][Full Text] [Related]
53. Lentiviral vectors: basic to translational.
Sakuma T; Barry MA; Ikeda Y
Biochem J; 2012 May; 443(3):603-18. PubMed ID: 22507128
[TBL] [Abstract][Full Text] [Related]
54. Lentiviral vectors.
Giry-Laterrière M; Verhoeyen E; Salmon P
Methods Mol Biol; 2011; 737():183-209. PubMed ID: 21590398
[TBL] [Abstract][Full Text] [Related]
55. Toolbox for retrovectorologists.
Pagès JC; Bru T
J Gene Med; 2004 Feb; 6 Suppl 1():S67-82. PubMed ID: 14978752
[TBL] [Abstract][Full Text] [Related]
56. From the natural evolution to the genetic manipulation of the host-range of retroviruses.
Dornburg R
Biol Chem; 1997 Jun; 378(6):457-68. PubMed ID: 9224924
[TBL] [Abstract][Full Text] [Related]
57. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
Bartosch B; Cosset FL
Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
[TBL] [Abstract][Full Text] [Related]
58. Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types.
Kasaraneni N; Chamoun-Emanuelli AM; Wright G; Chen Z
mBio; 2017 Dec; 8(6):. PubMed ID: 29233896
[TBL] [Abstract][Full Text] [Related]
59. Retroviral vectors for gene therapy.
Guntaka RV; Swamynathan SK
Indian J Exp Biol; 1998 Jun; 36(6):539-45. PubMed ID: 9731465
[TBL] [Abstract][Full Text] [Related]
60. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.
Maurice M; Verhoeyen E; Salmon P; Trono D; Russell SJ; Cosset FL
Blood; 2002 Apr; 99(7):2342-50. PubMed ID: 11895766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
